Osang Healthcare Co.,Ltd

KOSDAQ 036220.KQ

Osang Healthcare Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2023: 51.61%

Osang Healthcare Co.,Ltd Return on Capital Employed (ROCE) is 51.61% for the year ending December 31, 2023, a 100.04% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Osang Healthcare Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 25.80%, a 5,463.53% change year over year.
  • Osang Healthcare Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2021 was -0.48%, a -100.61% change year over year.
  • Osang Healthcare Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 78.23%, a 3,799.51% change year over year.
  • Osang Healthcare Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2019 was -2.11%, a -186.68% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
KOSDAQ: 036220.KQ

Osang Healthcare Co.,Ltd

CEO Man-Suk Ko
IPO Date March 13, 2024
Location South Korea
Headquarters 132, Anyangcheondong-ro
Employees 325
Sector Health Care
Industries
Biotechnology Medical Instruments Pharmaceuticals
Description

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang, South Korea.

StockViz Staff

January 15, 2025

Any question? Send us an email